Ghana News
Turkey Hikes Residence Permit Fees by Up to 930% for Ghanaians, Nigerians, and 36 Other African Nations
A six-month permit now costs $315, up from approximately $85, as Turkey overhauls its migration fee structure, affecting over 140 countries, including the United States, the United Kingdom, and Canada.
Turkey has commenced a sweeping increase in residence permit application fees, raising certain categories for nationals of Ghana, Nigeria, and approximately 36 other African countries by as much as 930 percent, the Directorate General of Migration Management announced at the weekend.
A total of about 140 countries across continents, including the United States of America, are also affected by the new residence permit hike. Almost all categories of residence permits are subject to the new rates — short-term tourist, family, for property owners, as well as permits related to investment and educational programs, including TOMER (Turkish Learning Center) courses.
The sharp increase took effect on May 1, 2026. Before the change, a Turkish lira equivalent of roughly $85 per year was charged as a residence permit fee. That framework has now been replaced with a sharply escalated tariff structure: a six-month permit now costs $315 (a 270% increase), and a one-year permit costs $631 (a 642% increase when annualised against the old $85 rate). A two-year permit is now $1,263, and a three-year permit costs $1,857.
Work visas have also increased significantly: a standard single-entry work permit now costs about 12,575 lira ($278), and a permanent one costs 125,800 lira ($2,784).
Ghana Among Nearly 40 African Nations Affected
For Ghanaians seeking to study, work, invest, or join family members in Turkey, the new fees represent a substantial financial barrier. Ghana is listed among the affected African nations, which include Nigeria, Kenya, Uganda, Rwanda, Senegal, Sierra Leone, Libya, Sudan, Zimbabwe, and Zambia, among others.
Notably, certain African countries were excluded from the permit hike: South Africa, Seychelles, Morocco, Tanzania, Algeria, Egypt, Cote d’Ivoire, Sao Tome and Principe, South Sudan, Togo, Cabo Verde, and Zambia will not face the increased rates, a differentiation that has raised questions about Turkey’s tiered approach to African migration policy.
No official data for Ghanaian residents was immediately available, but community sources indicate a growing Ghanaian presence in Istanbul and Ankara for education, commerce, and religious studies.
A Global Price Hike With Strategic Exemptions
The new pricing regime affects a wide range of countries across every continent. In addition to African nations, affected countries include:
- North America: United States, Canada
- Europe: United Kingdom, Germany, France, Italy, Netherlands, Switzerland, Sweden, Norway, Finland, Poland, Portugal, Romania, Greece
- Asia: China, India, Indonesia, Japan, Saudi Arabia, Qatar, United Arab Emirates, Israel, Iran, Kazakhstan
- Oceania: Australia, New Zealand
- South America & Caribbean: Brazil, Argentina, Chile, Jamaica, Haiti, Dominican Republic
The Turkish Migration Directorate noted that certain categories remain partially insulated. University students (excluding TOMER language-course participants) and long-term permanent residence applicants will continue to pay only the residence card fee, with no additional tax surcharge.
However, all other categories — short-term (touristic) residence permits, family residence permits, property-owner permits, residence permits linked to citizenship-by-investment applications, and TOMER-based permits — fall within the new pricing regime.
Visa Fee Also Increased
Foreign nationals who enter Turkey visa-free through a consulate-free entry and whose prior residence or work permit is inactive will also be required to pay a single-entry visa fee upon applying. That fee has been jacked up to $208 from $174 — a nearly 20 percent increase.
Implications for Ghanaians and West Africans
For Ghanaian students considering TOMER courses to learn Turkish before university enrollment, the new fees present a significant added cost. A typical TOMER course lasts six to eight months, meaning students would now need to budget $315 for their residence permit alone, on top of tuition, accommodation, and living expenses.
Similarly, Ghanaian property owners in Turkey, a small but growing group, particularly in Istanbul’s Esenyurt and Basaksehir districts, will face substantially higher renewal costs for their permits. Family residence permits, often used by Ghanaian spouses and children of Turkish residents or citizens, are also fully subject to the new tariff.
Turkey’s Shifting Migration Strategy
The dramatic fee increase comes as Turkey continues to host the world’s largest refugee population, over 3.6 million Syrians alone, and faces domestic political pressure to regulate immigration more tightly. By sharply raising permit fees for short-term and educational categories, Ankara appears to be signalling a shift away from open-door policies toward a more selective, revenue-driven migration model.
For Ghanaian professionals, students, and families with ties to Turkey, the message is clear: staying in Turkey has just become significantly more expensive.
In a powerful demonstration of local ownership, Ghanaian research institutions and pharmaceutical manufacturers are contributing an additional €425,000 of their own money to implement innovative health projects, signaling a robust commitment to advancing homegrown medical solutions beyond relying on foreign aid alone.
The co-funding is part of a €2 million grant package awarded under the PharmaVax Ghana program, backed by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU).
The initiative is designed to bridge the critical gap between scientific discovery and industrial-scale manufacturing within Ghana.
While the grants provide vital financial fuel, the local co-investment—which ranges from €10,000 to €150,000 across the eight winning projects—represents a crucial “skin in the game” approach.
It shows that local institutions are not merely passive recipients of aid, but active stakeholders willing to risk their own capital to bring products to the market. This practical commitment underscores the sustainability of the projects, ensuring they are not abandoned once international funding cycles end.
The projects span a wide range of medical priorities, including fast-dissolving oral tablets for child-friendly malaria treatment, AI-powered diagnostic tools for Mpox and malaria, standardized herbal treatments for hypertension and liver disease, and stability data for locally produced tetanus-diphtheria vaccines.
Highlighting the importance of this local participation, Dr. Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute (NVI), emphasized that the funds are meant to catalyze local capabilities.
“Ghana has the scientific talent, the research institutions and an increasingly capable pharmaceutical industry to develop health solutions that respond to our own priorities,” he stated. “By bringing these strengths together, we are creating the foundation for medicines and vaccines that are developed in Ghana, manufactured in Ghana, and have the potential to benefit the wider region.”
Ghana’s Minister of Health, Hon. Kwabena Mintah Akandoh, echoed this sentiment, noting that the initiative marks a journey where researchers and manufacturers collaborate to transform scientific discoveries into life-saving products.
The €425,000 in local contributions—combined with the €2 million in grants and technical assistance from the EU and Germany—positions Ghana as a rising hub for pharmaceutical industrialization in West Africa, moving the nation closer to health security and economic self-reliance.
Ghana News
From Default to Discipline: How Ghana is Legally Binding Itself to Prevent the Next Debt Crisis
Fresh off a landmark agreement with Belgium that eases its debt burden, Ghana’s Finance Minister, Dr. Cassiel Ato Forson, has unveiled a sweeping package of legal and institutional reforms designed to permanently prevent the country from sliding back into the fiscal chaos that triggered its 2022 sovereign default.
The deal with Belgium to restructure €163 million in debt owed to the country’s Export Credit Agency marks a pivotal step towards completing Ghana’s broader debt restructuring program. Crucially, the agreement frees up much-needed “fiscal space” by slashing the amount of national revenue consumed by debt servicing. Minister Forson revealed that Ghana’s debt-service burden has fallen drastically from a crippling peak of roughly 50% to 55% of national revenue to less than 20% today—a shift that directly impacts the government’s ability to fund schools, hospitals, and roads.
However, the most significant aspect of Ghana’s strategy is its attempt to codify fiscal prudence into law, ensuring that the discipline learned from the crisis is not lost by future administrations.
A Three-Pronged Strategy for Fiscal Discipline
1. The Commitment Authorization Regime
At the core of the immediate controls is a strict mandate for all Ministries, Departments, and Agencies (MDAs). Under the amended Public Financial Management Act, no government institution can initiate a contract for goods, services, or works without first securing commitment authorization from the Finance Minister . This process, integrated with the Ghana Integrated Financial Management Information System (GIFMIS), acts as a “roadblock” to prevent overspending and the accumulation of hidden arrears—a practice that historically poisoned the country’s finances.
2. Binding Fiscal Rules in Law
Beyond day-to-day controls, the government has instituted statutory targets to ensure long-term solvency. The Public Financial Management Act has been amended to require a minimum annual primary surplus of 1.5% of GDP and to cap the national debt-to-GDP ratio at 45% by 2034 . These are not policy recommendations but binding legal requirements, with the Finance Minister potentially facing censure for breaching these targets.
3. Independent Oversight Institutions
To guarantee that fiscal responsibility is maintained even after Ghana concludes its International Monetary Fund (IMF) programme, the government has established two powerful oversight bodies:
- The Value for Money Office: Parliament passed the Value-for-Money Office Bill in March 2026, creating an independent body to scrutinize major public expenditure. This office will combat inflated contracts, cost overruns, and abandoned projects by issuing mandatory “Value for Money Certificates” before major contracts are awarded.
- The Independent Fiscal Council: The government is establishing a council composed of locally appointed experts to provide advisory support on financial controls and fiscal decision-making . This council, scheduled to take effect after the IMF programme ends, aims to strengthen domestic oversight and accountability, ensuring that Ghana owns its fiscal destiny.
From Recovery to Sustainability
Finance Minister Ato Forson is clear about the goal: “We want to ensure that the fiscal rules that we have instituted today are enshrined in law, so that even if this government is not there, the next government will have to make sure that these fiscal rules are respected” .
The Belgium agreement is the immediate piece of good news that provides tangible relief—allowing Ghana to redirect more resources towards essential public services. But the real measure of Ghana’s recovery will be its ability to enforce these new legal shackles.
By moving from crisis management to institutionalized discipline, Ghana is attempting to break the cycle of over-borrowing, arrears, and economic collapse that has plagued the nation for decades.
In a significant boost to Africa’s push for pharmaceutical self-reliance, the European Union (EU) and Germany have injected €2 million into Ghana to bridge the critical gap between laboratory research and industrial-scale manufacturing.
The funding, awarded under the PharmaVax Ghana programme, has been distributed to eight groundbreaking research partnerships aimed at developing and manufacturing medicines and vaccines locally, drastically reducing the continent’s historical reliance on imported drugs.
The announcement came during the “Research Meets Manufacturing” Award Ceremony in Accra on August 19, co-hosted by Ghana’s National Vaccine Institute (NVI) and the German development agency GIZ.
The grants are jointly funded by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU) as part of the broader Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+).
This strategic geopolitical and economic move underscores Western Europe’s commitment to backing local African manufacturing ecosystems, countering the long-standing structural imbalance where Africa imports over 90% of its pharmaceuticals.
“A ceremony marks the beginning of an important journey—a journey that brings researchers, manufacturers, government and international partners together to transform scientific discoveries into medicines and vaccines that save and improve lives,” said Hon. Kwabena Mintah Akandoh, Ghana’s Minister of Health, during the event.
Innovation Across the Health Spectrum
The eight winning projects, selected from 43 competitive proposals by an independent committee of nine Ghanaian experts, represent the breadth of the nation’s scientific talent. They include:
- AI-driven monoclonal antibodies and diagnostics for Mpox and malaria, using a Ghanaian artificial intelligence platform.
- Fast-dissolving oral tablets for the treatment of malaria in children, addressing critical issues of accurate dosing.
- Clinical trials for locally developed herbal treatments for prostate health, hypertension, and alcohol-related liver disease.
- Stability data generation to support regulatory approval of locally produced tetanus-diphtheria vaccines, snake venom antiserum, and pain management therapies.
A Foundation for Health Sovereignty
Dr. Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute, emphasized that the grants go far beyond financial aid.
“Ghana has the scientific talent, the research institutions and an increasingly capable pharmaceutical industry to develop health solutions that respond to our own priorities,” Dr. Sodzi-Tettey stated. “By bringing these strengths together, we are creating the foundation for medicines and vaccines that are developed in Ghana, manufactured in Ghana, and have the potential to benefit the wider region.”
Notably, Ghanaian partners are contributing an additional €425,000 towards implementing their projects, demonstrating a strong local commitment to advancing homegrown innovation. Alongside the direct funding, the projects will also receive technical assistance, networking opportunities, and knowledge exchange to ensure long-term commercial viability.
As the global health community increasingly looks to localized manufacturing to secure supply chains, this €2 million initiative serves as a pivotal case study.
It represents a concrete, actionable blueprint for how international development capital can ignite the “Made in Africa” pharmaceutical industrial wave, securing the continent’s health security and driving economic development from within.
Ghanaian Firms Inject €425,000 of Own Funds to Ignite ‘Made in Ghana’ Health Innovation
From Default to Discipline: How Ghana is Legally Binding Itself to Prevent the Next Debt Crisis
